Article citationsMore>>

Algan, O., Tabesh, T., Hanlon, A., Hogan, W.M., Boente, M. and Lanciano, R.M. (1996) Improved Outcome in Patients Treated with Postoperative Radiation Therapy for Pathologic Stage I/II Endometrial Cancer. International Journal of Radiation Oncology*Biology*Physics, 35, 925-933.
http://dx.doi.org/10.1016/0360-3016(96)00188-5

has been cited by the following article:

• TITLE: Adjuvant External Beam Radiotherapy ± Brachytherapy in Endometrial Cancer: A Retrospective Study from Faculty of Medicine, Chiang Mai University

  AUTHORS: Ekkasit Tharavichitkul, Sukon Prasitwattanaseree, Patrinee Traisathit, Cholthicha Thipmate, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Razvan M. Galalae, Imjai Chitapanarux

  KEYWORDS: Endometrial Cancer, Adjuvant Treatment, External Beam Radiotherapy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.2, January 29, 2015

  ABSTRACT: Purpose: To report the retrospective study of external beam radiotherapy (EBRT) ± intravaginal brachytherapy (IVBT) as adjuvant treatment for endometrial cancer. Materials and Methods: From 2001-2009, 152 patients received complete surgical staging for endometrial carcinoma and were designed by a multidisciplinary team to receive EBRT ± IVBT. The treatment results and late toxicities were evaluated and recorded. Results: At the median follow-up time of 43 months, the disease-free survival, metastasis-free survival and overall survival rates were 96.9%, 96.9% and 96.9%, respectively. Stage and age showed the statistical significance with the p-value of less than 0.001. From five to ten percent of patients developed Grades 1-2 late gastrointestinal and genitourinary toxicities, respectively. Conclusion: The using of adjuvant EBRT ± IVBT for endometrialcarcinoma yielded treatment results and acceptable toxicities.